IADR 2021: Cortexyme Presents New Data on Potential New Periodontal Disease Treatment
Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer’s disease with top-line data expected in the fourth quarter of 2021.
Industry News
Industry News
Poor Oral Hygiene May Lead to Metabolic Syndrome
Infection with Porphyromonas gingivalis, the bacterium that causes periodontal disease, causes skeletal metabolic dysfunction, the precursor to metabolic syndrome, by altering the composition.
Industry News
P Gingivalis Borrows Growth Molecules from V Parvula to Cause Gum Disease
Otherwise harmless bacteria such as Veillonella parvula help Porphyromonas gingivalis multiply and cause gum disease, according to a team of researchers led by.
Industry News
Oral Pathogens Induce Oral Cancer
Pathogens found in tissues that surround the teeth contribute to a highly aggressive type of oral cancer, according to a multi-institution team of.
Industry News
Oral Bacteria Triggers Alzheimer’s-Like Neuropathology
The oral bacteria Porphyromonas gingivalis invades neurons and triggers Alzheimer’s-like neuropathology, according to research funded by the clinical stage biopharmaceutical company Cortexyme.
Industry News
Potential Alzheimer’s Disease Therapy Targets Oral Bacteria
Porphyromonas gingivalis doesn’t just cause periodontal disease. It also has been linked with Alzheimer’s and other degenerative diseases. Now, pharmaceutical company Cortexyme Inc.
Industry News
Another Study Links Alzheimer’s Disease With Oral Bacteria
Porphyromonas gingivalis can travel throughout the body and exude toxins connected with Alzheimer’s disease, rheumatoid arthritis, and aspiration pneumonia, report researchers at the.
Industry News
Targeting Bacterial Fimbriae May Inhibit Periodontitis
Porphyromonas gingivalis assembles hair-like structures on its surface called fimbriae for adhesion in the oral cavity, helping it initiate and sustain infection and.
Industry News
Vaccine Proves Effective Against P Gingivalis
SutroVax has developed a multivalent vaccine that has demonstrated protective immunity against Porphyromonas gingivalis (Pg), a common bacteria believed to be responsible for.
Industry News
Oral Bacteria Linked to Alzheimer’s Disease
Porphyromonas gingivalis (Pg) plays a role in driving Alzheimer’s disease (AD) pathology, according to researchers at Cortexyme. But the privately held, clinical-stage pharmaceutical.
